NL177747C - PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-THROMBOSIS ACTION, AND PROCESS FOR PREPARING NŸ2-ARYLSULPHONYL-L-ARGININE DERIVATIVES USABLE FOR USE IN SUCH PREPARATIONS. - Google Patents
PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-THROMBOSIS ACTION, AND PROCESS FOR PREPARING NŸ2-ARYLSULPHONYL-L-ARGININE DERIVATIVES USABLE FOR USE IN SUCH PREPARATIONS.Info
- Publication number
- NL177747C NL177747C NLAANVRAGE7613660,A NL7613660A NL177747C NL 177747 C NL177747 C NL 177747C NL 7613660 A NL7613660 A NL 7613660A NL 177747 C NL177747 C NL 177747C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- preparations
- arylsulphonyl
- arginine derivatives
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/22—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one naphthalene or hydrogenated naphthalene ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/638,985 US4055636A (en) | 1974-11-08 | 1975-12-09 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/646,522 US4018915A (en) | 1976-01-05 | 1976-01-05 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/649,219 US4018913A (en) | 1976-01-14 | 1976-01-14 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/653,217 US4055651A (en) | 1974-11-08 | 1976-01-28 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/656,014 US4041156A (en) | 1974-11-08 | 1976-02-06 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/656,870 US4046876A (en) | 1974-11-08 | 1976-02-10 | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
JP3062176A JPS52113919A (en) | 1976-03-19 | 1976-03-19 | Preparation of tertiary alkylester of n-substituted amino acid or thei r acid salts |
US05/669,743 US4070457A (en) | 1974-11-08 | 1976-03-24 | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/707,536 US4036955A (en) | 1976-07-22 | 1976-07-22 | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/713,486 US4073914A (en) | 1974-11-08 | 1976-08-11 | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US05/723,474 US4096255A (en) | 1974-11-08 | 1976-09-14 | N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods |
US05/728,051 US4104392A (en) | 1974-11-08 | 1976-09-30 | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7613660A NL7613660A (en) | 1977-06-13 |
NL177747B NL177747B (en) | 1985-06-17 |
NL177747C true NL177747C (en) | 1985-11-18 |
Family
ID=27583260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7613660,A NL177747C (en) | 1975-12-09 | 1976-12-08 | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-THROMBOSIS ACTION, AND PROCESS FOR PREPARING NŸ2-ARYLSULPHONYL-L-ARGININE DERIVATIVES USABLE FOR USE IN SUCH PREPARATIONS. |
Country Status (12)
Country | Link |
---|---|
BE (1) | BE849196A (en) |
CA (1) | CA1102316A (en) |
DD (1) | DD128681A5 (en) |
DE (1) | DE2655636A1 (en) |
DK (1) | DK154289C (en) |
FI (1) | FI65240C (en) |
FR (1) | FR2334349A1 (en) |
GR (1) | GR63103B (en) |
LU (1) | LU76347A1 (en) |
NL (1) | NL177747C (en) |
NO (1) | NO145379C (en) |
PT (1) | PT65934B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8203887D0 (en) * | 1982-06-23 | 1982-06-23 | Kabivitrum Ab | NEW TROMBIN INHIBITIVE ASSOCIATIONS |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
US6492421B1 (en) | 1997-07-31 | 2002-12-10 | Athena Neurosciences, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6559127B1 (en) | 1997-07-31 | 2003-05-06 | Athena Neurosciences, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
CN1133648C (en) * | 1997-07-31 | 2004-01-07 | 伊兰药品公司 | Substituted phenylalanine-type compounds that inhibit VLA-4 mediated leukocyte adhesion |
US6939855B2 (en) | 1997-07-31 | 2005-09-06 | Elan Pharmaceuticals, Inc. | Anti-inflammatory compositions and method |
US6583139B1 (en) | 1997-07-31 | 2003-06-24 | Eugene D. Thorsett | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6423688B1 (en) | 1997-07-31 | 2002-07-23 | Athena Neurosciences, Inc. | Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6489300B1 (en) | 1997-07-31 | 2002-12-03 | Eugene D. Thorsett | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6291453B1 (en) | 1997-07-31 | 2001-09-18 | Athena Neurosciences, Inc. | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6362341B1 (en) | 1997-07-31 | 2002-03-26 | Athena Neurosciences, Inc. | Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US7030114B1 (en) | 1997-07-31 | 2006-04-18 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
JP2002535314A (en) | 1999-01-22 | 2002-10-22 | エラン ファーマシューティカルズ,インコーポレイテッド | Compounds inhibiting leukocyte adhesion mediated by VLA-4 |
CA2359112A1 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
MXPA01007394A (en) * | 1999-01-25 | 2002-04-09 | Wyeth Corp | Compounds which inhibit leukocyte adhesion mediated by vla-4. |
US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US6407066B1 (en) | 1999-01-26 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
NZ567270A (en) | 2005-09-29 | 2011-06-30 | Elan Pharm Inc | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
CN101273035A (en) | 2005-09-29 | 2008-09-24 | 伊兰制药公司 | Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EA017110B1 (en) | 2006-02-27 | 2012-09-28 | Элан Фамэсьютикэлс, Инк. | PYRIMIDINYLSULFONAMIDE COMPOUNDS (VARIANTS), METHOD FOR PREPARING SAME (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR TREATING A DISEASE MEDIATED BY α4 INTEGRIN, METHOD FOR REDUCING AND/OR PREVENTING AN INFLAMMATORY COMPONENT OF A DISEASE OR AN AUTOIMMUNE RESPONSE |
MX2011011326A (en) | 2009-04-27 | 2012-02-13 | Elan Pharm Inc | Pyridinone antagonists of alpha-4 integrins. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL165652C (en) * | 1973-08-13 | 1981-05-15 | Mitsubishi Chem Ind | METHOD FOR PREPARING AN ANTI-THROMBOSIS ACTION PREPARATION AND / OR BLOOD THROMBINE DIAGNOSTIC BASED ON L-ARGININE DERIVATIVES, THE PREPARED PREPARATION, THE PREPARED DIAGNOSTIC AND METHOD OF PREPARATION. |
-
1976
- 1976-11-24 CA CA266,501A patent/CA1102316A/en not_active Expired
- 1976-12-07 PT PT65934A patent/PT65934B/en unknown
- 1976-12-08 DK DK550576A patent/DK154289C/en active
- 1976-12-08 DE DE19762655636 patent/DE2655636A1/en active Granted
- 1976-12-08 NO NO76764186A patent/NO145379C/en unknown
- 1976-12-08 FI FI763528A patent/FI65240C/en not_active IP Right Cessation
- 1976-12-08 NL NLAANVRAGE7613660,A patent/NL177747C/en not_active IP Right Cessation
- 1976-12-08 DD DD7600196195A patent/DD128681A5/en unknown
- 1976-12-08 LU LU76347A patent/LU76347A1/xx unknown
- 1976-12-08 GR GR52354A patent/GR63103B/en unknown
- 1976-12-08 BE BE173077A patent/BE849196A/en not_active IP Right Cessation
- 1976-12-09 FR FR7637163A patent/FR2334349A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
DE2655636C2 (en) | 1993-03-11 |
FI65240C (en) | 1984-04-10 |
DK550576A (en) | 1977-06-10 |
NO145379B (en) | 1981-11-30 |
GR63103B (en) | 1979-09-05 |
DD128681A5 (en) | 1977-12-07 |
NO764186L (en) | 1977-06-10 |
FR2334349A1 (en) | 1977-07-08 |
CA1102316A (en) | 1981-06-02 |
NO145379C (en) | 1982-03-10 |
FR2334349B1 (en) | 1983-07-22 |
BE849196A (en) | 1977-06-08 |
FI65240B (en) | 1983-12-30 |
PT65934A (en) | 1977-01-01 |
LU76347A1 (en) | 1977-06-24 |
NL7613660A (en) | 1977-06-13 |
NL177747B (en) | 1985-06-17 |
DK154289C (en) | 1989-03-28 |
FI763528A (en) | 1977-06-10 |
PT65934B (en) | 1978-06-13 |
DE2655636A1 (en) | 1977-06-23 |
DK154289B (en) | 1988-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL177747C (en) | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTI-THROMBOSIS ACTION, AND PROCESS FOR PREPARING NŸ2-ARYLSULPHONYL-L-ARGININE DERIVATIVES USABLE FOR USE IN SUCH PREPARATIONS. | |
NL177405C (en) | METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING MEDICINAL COMPOUNDS, SUITABLE FOR USE IN THESE PREPARATIONS. | |
NL174348B (en) | METHOD FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE FOREGOING METHOD | |
NL181628C (en) | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH PROSTAGLANDINE-LIKE ACTION, AND METHOD FOR PREPARING 9-ALFA, 11-ALFA, 15-ALFA-TRIHYDROXY-PROSTA-4,5,13-TRI-ACID DERIVATIVES, PREVIOUSLY USED | |
NL7809404A (en) | THIAZOLIC DERIVATIVES AND THIAZOLIC DERIVATIVES CONTAINING PHARMACEUTICAL PREPARATIONS AND METHODS FOR PREPARING ONE AND OTHER. | |
NL7703898A (en) | PROCESS FOR PREPARING 2-SUBSTITUTED TRANS-HEXAHYDROPYRIDOINDOLS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SO FORMED. | |
NL155045B (en) | PROCESS FOR PREPARING ORGANOSILICUM PREPARATIONS AND FOR THE ANTI-ADHESIA LAYER IN OBJECTS USING THESE PREPARATIONS. | |
NL169076C (en) | METHOD FOR PREPARING OR MANUFACTURING PHARMACOLOGICAL PREPARATIONS WITH ANALGETIC AND ANTIPYRETIC ACTION, AND METHOD FOR PREPARING MEDICINAL COMPOUNDS, SUITABLE FOR USE IN SUCH PREPARATIONS | |
NL167685C (en) | METHOD FOR PREPARING OR MANUFACTURING PHARMACEUTICAL PREPARATIONS, AND METHOD FOR PREPARING ALKANOLAMINE DERIVATIVES SUITABLE FOR USE IN THIS PROCESS | |
NL177917B (en) | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS BASED ON 1-SUBSTITUTED PYRAZOLONE-5 DERIVATIVES, AND METHOD FOR PREPARING 1-SUBSTITUISED-PERSOZEDUZOLATED PYRAZOLATED PREPARATIONS. | |
NL7612937A (en) | THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM. | |
NL161451B (en) | PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PREPARING A COMPOUND, SUITABLE FOR USE IN THE PREPARATION OF THIS PREPARATION. | |
NL7501914A (en) | PROCESS FOR THE PREPARATION OF CEPHALOSSPORINS AND THEIR USE AS PHARMACEUTICAL PREPARATIONS. | |
NL7612941A (en) | THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM. | |
NL7602391A (en) | METHODS FOR PREPARING AND USING L-3- (3,4-DIHYDROXY-PHENYL) -2-METHYL-ALANINE -PEPTIDES. | |
NL188944C (en) | METHOD FOR PREPARING OMEGA-AMINO-KOXYBENZENE DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEIR USE AS AN ACTIVE COMPOUND | |
NL184111C (en) | PROCESS FOR PREPARING ANDROSTONE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE. | |
NL7612939A (en) | THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM. | |
NL7612942A (en) | THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM. | |
NL7604894A (en) | PROCEDURES FOR PREPARING AND USING CHINAZOLINE DERIVATIVES. | |
NL161154B (en) | PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A 4-OXAZOLINE-2-ON-DERIVATIVE, PREPARATION AND PROCEDURE FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE SAID PROCESS. | |
NL7612940A (en) | THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM. | |
NL7600045A (en) | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS. | |
NL174042B (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON A 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVAAT, AND METHOD FOR PRODUCING 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVATEN, SUITABLE FOR USE IN SUCH PREPARATIONS. | |
NL175995C (en) | METHOD FOR PREPARING ANTI-ALLERGIC MEDICINAL PRODUCTS AND THE ACTIVE SUBSTANCES SUITABLE THEREFOR. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
TNT | Modifications of names of proprietors of patents or applicants of examined patent applications |
Owner name: MITSUBISHI KASEI CORPORATION |
|
V1 | Lapsed because of non-payment of the annual fee |